Efalizumab-induced aseptic meningitis.
Kluger
N
N
Girard
C
C
Gonzalez
V
V
Guillot
B
B
Bessis
D
D
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D061067:Antibodies, Monoclonal, Humanized; D003879:Dermatologic Agents / Q000009:adverse effects*; D005260:Female; D006801:Humans; D008582:Meningitis, Aseptic / Q000139:chemically induced*; D011565:Psoriasis / Q000188:drug therapy*
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D003879:Dermatologic Agents; C472181:efalizumab